Inari Medical
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Inari Medical sits in the top decile of US sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count).
Inari Medical: 12 sponsored US clinical trials, 5 recruiting.
Inari Medical sponsors 12 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 7 completed. The most-studied condition in this pipeline is Pulmonary Embolism, with 2 trials.
Top-decile sponsor footprint
Inari Medical ranks in the top decile of sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
12 total, page 1 of 1
The ArtixASCEND Study
NCT07135895
The PERSEVERE Study
NCT06588634
RevCore for In Stent Thrombosis
NCT06394739
The PEERLESS II Study
NCT06055920
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
NCT05701917
The Protrieve PROTECTOR Study
NCT06495996
FlowTriever2 Pulmonary Embolectomy Clinical Study
NCT05560763
The PEERLESS Study
NCT05111613
FlowTriever for Acute Massive Pulmonary Embolism (FLAME)
NCT04795167
FlowTriever All-Comer Registry for Patient Safety and Hemodynamics
NCT03761173
ClotTriever Outcomes (CLOUT) Registry
NCT03575364
FlowTriever Pulmonary Embolectomy Clinical Study
NCT02692586
What is open in the Inari Medical pipeline
5 recruiting of 12 indexed (42% open); 7 completed (58%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Pulmonary Embolism (2 trials), 6 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Inari Medical: open-pipeline peers nationwide
Peers matched on 12 registered trials and 42% open enrollment, not the therapeutic-area sidebar.
Inari Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 12 trials (± recruiting share)
- Alachua Government Services · 12 trials · 0% recruiting
- Allergy Therapeutics · 12 trials · 0% recruiting
- Ampio Pharmaceuticals. · 12 trials · 0% recruiting
- Angiodynamics · 12 trials · 17% recruiting
Sponsors near 42% open enrollment (± trial volume)
- Arthrex · 42% recruiting · 12 trials
- Diwakar Davar · 42% recruiting · 12 trials
- Exactech · 42% recruiting · 12 trials
- Massachusetts Institute of Technology · 42% recruiting · 24 trials
Related
What to do with this Inari Medical page
12 registered trials is a research-attention snapshot, not an endorsement of Inari Medical or any single study.
- 5 of Inari Medical's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Pulmonary Embolism is the condition Inari Medical studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pulmonary Embolism trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Inari Medical pipeline card: 12 registered trials from official public datasets.Report a data error.